Pathway nets another patent for atherectomy system
Pathway Medical Technologies, a provider of endovascular treatments for peripheral arterial disease (PAD), was recently granted another patent for its Pathway PV atherectomy system.

The issuance of this latest patent enhances the intellectual property related to Pathway’s atherectomy system, which is designed to treat the arterial disease found in the legs, according to the company.

The Kirkland, Wash.-based Pathway has a total of three patents issued by the U.S. patent office relating to differential cutting and the removal of atherosclerotic plaque for its rotational atherectomy system with several other patents pending.